NDC properties for NDC 9 51759-412
NDC item 51759041222
| NDC 9 | 51759-412 |
|---|---|
| NDC 10 | 51759-412-22 |
| NDC Item | 51759041222 |
| packaging | 2 KIT in 1 CARTON (51759-412-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-624-31) * .4 mL in 1 POUCH |
| BLA | BLA761299 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-11-19 |
| Marketing status | ACTIVE |
NDC item 51759062431
| NDC 9 | 51759-624 |
|---|---|
| NDC 10 | 51759-624-31 |
| NDC Item | 51759062431 |
| packaging | 0.4 mL in 1 SYRINGE |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |